{"product_id":"neurotrauma-9781405185646","title":"Neurotrauma","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003ci\u003eNeurotrauma: Managing Patients with Head Injuries\u003c\/i\u003e is a comprehensive, holistic, evidence-based approach to the primary, secondary and tertiary care of a person with neurotrauma.\u003c\/p\u003e \u003cp\u003eUsing a patient-centred needs approach to enhance the quality of care of head injured patients, family and carers, this multidisciplinary bookenables the reader to apply the knowledge, skills and attitudes learned to the practice of neurotrauma in all settings. It explores:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eAnatomy and physiology of the brain\u003c\/li\u003e \u003cli\u003ePharmacology for neurotrauma patients\u003c\/li\u003e \u003cli\u003eAssessment of the patient with neurotrauma\u003c\/li\u003e \u003cli\u003eManagement of neurotrauma in a range of settings including at the scene, in the emergency department, and at the hospital\u003c\/li\u003e \u003cli\u003eNeuro-rehabilitation\u003c\/li\u003e \u003cli\u003eCommunity care\u003c\/li\u003e \u003cli\u003eNursing management of the patient\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThis practical resource includes activities, exercises, and ethical and legal considerations throughout, making it ideal reading for all sta\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003ePreface xi\u003c\/p\u003e \u003cp\u003eDedication xii\u003c\/p\u003e \u003cp\u003eAcknowledgements xiii\u003c\/p\u003e \u003cp\u003eContributor Details xiv\u003c\/p\u003e \u003cp\u003eAbbreviations xviii\u003c\/p\u003e \u003cp\u003eList of Tables and Figures xx\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1 Foundations for Practice 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 1\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 The Patient’s Journey 3\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 3\u003c\/p\u003e \u003cp\u003eCare pathways: policies and guidelines 4\u003c\/p\u003e \u003cp\u003eIntegrated care pathways 4\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Philosophy 6\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 6\u003c\/p\u003e \u003cp\u003eConclusion 9\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 The Needs Approach Model 11\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 11\u003c\/p\u003e \u003cp\u003eWhat is a need? 11\u003c\/p\u003e \u003cp\u003eStructure of the Needs Approach Model 11\u003c\/p\u003e \u003cp\u003eUse of the model 12\u003c\/p\u003e \u003cp\u003eAssessing the patient’s needs 12\u003c\/p\u003e \u003cp\u003ePlanning 13\u003c\/p\u003e \u003cp\u003eGoal setting 14\u003c\/p\u003e \u003cp\u003eImplementation 14\u003c\/p\u003e \u003cp\u003eEvaluation 14\u003c\/p\u003e \u003cp\u003eRisk 14\u003c\/p\u003e \u003cp\u003eThe miraculous recovery 23\u003c\/p\u003e \u003cp\u003eNursing diagnosis 26\u003c\/p\u003e \u003cp\u003eConclusion 28\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 The Patient Matters 31\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell, an anonymous carer and Sue Mottram\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eThe patient 31\u003c\/p\u003e \u003cp\u003eFamily and carers 31\u003c\/p\u003e \u003cp\u003eConclusion 37\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Multidisciplinary Management 38\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell and Katie Searle\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 38\u003c\/p\u003e \u003cp\u003eStaffing 39\u003c\/p\u003e \u003cp\u003eSpeech and language therapy services 40\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Physiotherapy 43\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJude Fewings\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 43\u003c\/p\u003e \u003cp\u003eRespiratory care 43\u003c\/p\u003e \u003cp\u003ePositioning 43\u003c\/p\u003e \u003cp\u003eMusculoskeletal integrity and neuromuscular status 44\u003c\/p\u003e \u003cp\u003eSummary 44\u003c\/p\u003e \u003cp\u003eRehabilitation and motor control theories 45\u003c\/p\u003e \u003cp\u003ePosture and seating 45\u003c\/p\u003e \u003cp\u003eConclusion 46\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Neuropsychology 47\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eMichelle Smith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 47\u003c\/p\u003e \u003cp\u003eWhat is clinical neuropsychology? 47\u003c\/p\u003e \u003cp\u003eWho is a clinical neuropsychologist? 47\u003c\/p\u003e \u003cp\u003eWhat is the role of the clinical neuropsychologist in the management of TBI? 47\u003c\/p\u003e \u003cp\u003eNeuropsychological functions 47\u003c\/p\u003e \u003cp\u003eThe patient’s neuropsychological journey 49\u003c\/p\u003e \u003cp\u003eAdditional factors influencing neuropsychological functioning 50\u003c\/p\u003e \u003cp\u003eOther issues and considerations 51\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Social Considerations 52\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJudi Thomson and Anthony Gilbert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eThe role of the social worker 52\u003c\/p\u003e \u003cp\u003eSocial issues 54\u003c\/p\u003e \u003cp\u003eConclusion 56\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Occupational Therapy 57\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eDanielle Williams\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2 Pre-requisite Knowledge 61\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 61\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Epidemiology 63\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 63\u003c\/p\u003e \u003cp\u003eSeverity of injury 63\u003c\/p\u003e \u003cp\u003eHospital attendance 64\u003c\/p\u003e \u003cp\u003eIncidence 64\u003c\/p\u003e \u003cp\u003ePrevalence of head injury 64\u003c\/p\u003e \u003cp\u003eAge distribution 65\u003c\/p\u003e \u003cp\u003eGender distribution 65\u003c\/p\u003e \u003cp\u003eRace and ethnicity 65\u003c\/p\u003e \u003cp\u003eMechanism of injury 65\u003c\/p\u003e \u003cp\u003eSeasonal variation 66\u003c\/p\u003e \u003cp\u003ePredisposition 66\u003c\/p\u003e \u003cp\u003eUse of alcohol 66\u003c\/p\u003e \u003cp\u003eHead injury mortality 66\u003c\/p\u003e \u003cp\u003eConclusion 66\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Prevention of Head Injuries 68\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 68\u003c\/p\u003e \u003cp\u003eRecommendations 68\u003c\/p\u003e \u003cp\u003eRoad traffic accidents (RTAs) 69\u003c\/p\u003e \u003cp\u003eAction regarding the use of prescription, over the counter and illicit drugs 70\u003c\/p\u003e \u003cp\u003ePrevention of sports injuries 71\u003c\/p\u003e \u003cp\u003eCare of older people 71\u003c\/p\u003e \u003cp\u003eInterpersonal violence 71\u003c\/p\u003e \u003cp\u003eConclusion 72\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Applied Anatomy and Physiology 74\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 74\u003c\/p\u003e \u003cp\u003eThe nervous system 74\u003c\/p\u003e \u003cp\u003eThe scalp 74\u003c\/p\u003e \u003cp\u003eThe skull 75\u003c\/p\u003e \u003cp\u003eStructure of the brain 84\u003c\/p\u003e \u003cp\u003eAdditional concepts related to neurophysiology 102\u003c\/p\u003e \u003cp\u003eAcid-base balance 102\u003c\/p\u003e \u003cp\u003eSummary 105\u003c\/p\u003e \u003cp\u003eConclusion 106\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Investigations 108\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Pharmacology for Neurotrauma Patients 126\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell and Penny Franklin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 126\u003c\/p\u003e \u003cp\u003eAnaesthetic agents 127\u003c\/p\u003e \u003cp\u003eAnalgesics 127\u003c\/p\u003e \u003cp\u003eDiuretics 127\u003c\/p\u003e \u003cp\u003eAnti-epileptic drugs 127\u003c\/p\u003e \u003cp\u003eAnticoagulants 127\u003c\/p\u003e \u003cp\u003eAntiemetics 127\u003c\/p\u003e \u003cp\u003eLaxatives 127\u003c\/p\u003e \u003cp\u003eConclusion 127\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Applied Microbiology 129\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 129\u003c\/p\u003e \u003cp\u003eMeningitis 129\u003c\/p\u003e \u003cp\u003eEncephalitis 130\u003c\/p\u003e \u003cp\u003eBrain abscess 131\u003c\/p\u003e \u003cp\u003eConclusion 133\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 3 Features of Neurotrauma 135\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 135\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Classification of Traumatic Brain Injury 137\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eZuhair Noori and Nadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 137\u003c\/p\u003e \u003cp\u003ePrimary and secondary brain injury 137\u003c\/p\u003e \u003cp\u003eOpen and closed head injury 139\u003c\/p\u003e \u003cp\u003eConclusion 140\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Raised Intracranial Pressure 141\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 141\u003c\/p\u003e \u003cp\u003eDefinition 141\u003c\/p\u003e \u003cp\u003eCause of increased intracranial pressure 141\u003c\/p\u003e \u003cp\u003eDiagnosis 141\u003c\/p\u003e \u003cp\u003eInvestigations 142\u003c\/p\u003e \u003cp\u003eTreatment 142\u003c\/p\u003e \u003cp\u003eManagement of the patient 142\u003c\/p\u003e \u003cp\u003eConclusion 143\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Assessment of the Patient with Neurotrauma 144\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 144\u003c\/p\u003e \u003cp\u003eGeneral principles 144\u003c\/p\u003e \u003cp\u003eNeurological observations 146\u003c\/p\u003e \u003cp\u003eVital signs 151\u003c\/p\u003e \u003cp\u003eRecording the observations 152\u003c\/p\u003e \u003cp\u003eUndertaking a comprehensive CNS examination 152\u003c\/p\u003e \u003cp\u003eRecording the assessment 160\u003c\/p\u003e \u003cp\u003eConclusion 160\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 4 Management of Neurotrauma 161\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 161\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Management of Neurotrauma at the Scene 163\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eHenry Guly\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 163\u003c\/p\u003e \u003cp\u003eSevere and moderate head injury 163\u003c\/p\u003e \u003cp\u003eAirway with cervical spine protection 164\u003c\/p\u003e \u003cp\u003eBreathing 164\u003c\/p\u003e \u003cp\u003eCirculation 164\u003c\/p\u003e \u003cp\u003eDisability 165\u003c\/p\u003e \u003cp\u003eExposure and environment 165\u003c\/p\u003e \u003cp\u003eMinor head injury 166\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20 Management of Neurotrauma on Transfer 168\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eHenry Guly\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 168\u003c\/p\u003e \u003cp\u003eAirway with cervical spine protection 168\u003c\/p\u003e \u003cp\u003eBreathing 169\u003c\/p\u003e \u003cp\u003eCirculation 169\u003c\/p\u003e \u003cp\u003eDisability 169\u003c\/p\u003e \u003cp\u003eExposure 169\u003c\/p\u003e \u003cp\u003eOther 169\u003c\/p\u003e \u003cp\u003eWho should accompany the patient? 169\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21 Management of Neurotrauma in the Emergency Department 171\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eHenry Guly\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 171\u003c\/p\u003e \u003cp\u003ePreparing for the arrival of a seriously injured patient 171\u003c\/p\u003e \u003cp\u003eSevere and moderate head injury 171\u003c\/p\u003e \u003cp\u003eMinor head injury 176\u003c\/p\u003e \u003cp\u003eAdmission 178\u003c\/p\u003e \u003cp\u003eDischarge from the ED 178\u003c\/p\u003e \u003cp\u003eManagement of patients who are admitted for observation 178\u003c\/p\u003e \u003cp\u003eSocial aspects 179\u003c\/p\u003e \u003cp\u003e\u003cb\u003e22 Hospital Management of Neurotrauma 182\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eKevin Tsang and Peter Whitfield\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 182\u003c\/p\u003e \u003cp\u003eInitial assessment of trauma patients 182\u003c\/p\u003e \u003cp\u003eManagement in the neuroscience unit 184\u003c\/p\u003e \u003cp\u003eIntensive care management 185\u003c\/p\u003e \u003cp\u003eFurther management and prognosis 191\u003c\/p\u003e \u003cp\u003e\u003cb\u003e23 Nursing the Patient with Neurotrauma 194\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 194\u003c\/p\u003e \u003cp\u003eAdvocate 194\u003c\/p\u003e \u003cp\u003eEssential nursing skills 195\u003c\/p\u003e \u003cp\u003eTherapeutic practice 195\u003c\/p\u003e \u003cp\u003eCo-ordination 196\u003c\/p\u003e \u003cp\u003eClinical governance 196\u003c\/p\u003e \u003cp\u003eAdvice\/counselling 196\u003c\/p\u003e \u003cp\u003ePolitical awareness 196\u003c\/p\u003e \u003cp\u003eEducation 196\u003c\/p\u003e \u003cp\u003eResearch 196\u003c\/p\u003e \u003cp\u003eEthical considerations 196\u003c\/p\u003e \u003cp\u003eRehabilitation nursing 196\u003c\/p\u003e \u003cp\u003eActivities 234\u003c\/p\u003e \u003cp\u003e\u003cb\u003e24 Prognosis and Patient Outcome 235\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eZuhair Noori and Nadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 235\u003c\/p\u003e \u003cp\u003eFactors predicting prognosis after head injury 236\u003c\/p\u003e \u003cp\u003eOutcome measures 236\u003c\/p\u003e \u003cp\u003eReturn to work 237\u003c\/p\u003e \u003cp\u003eQuality of everyday life 237\u003c\/p\u003e \u003cp\u003eConclusion 237\u003c\/p\u003e \u003cp\u003e\u003cb\u003e25 Dying and Death 238\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eZuhair Noori and Nadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 238\u003c\/p\u003e \u003cp\u003eThe family 239\u003c\/p\u003e \u003cp\u003eBrain death 239\u003c\/p\u003e \u003cp\u003eConclusion 241\u003c\/p\u003e \u003cp\u003eActivities 241\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 5 Neurorehabilitation 243\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 243\u003c\/p\u003e \u003cp\u003e\u003cb\u003e26 Sequelae of Neurotrauma 245\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 245\u003c\/p\u003e \u003cp\u003eAdditional information about some sequelae 247\u003c\/p\u003e \u003cp\u003eConclusion 249\u003c\/p\u003e \u003cp\u003e\u003cb\u003e27 Neurorehabilitation 250\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eZuhair Noori and Nadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 250\u003c\/p\u003e \u003cp\u003eDefinition of rehabilitation 251\u003c\/p\u003e \u003cp\u003eLevels of rehabilitation 251\u003c\/p\u003e \u003cp\u003eSettings for rehabilitation 252\u003c\/p\u003e \u003cp\u003eRehabilitation costs 252\u003c\/p\u003e \u003cp\u003eStaffing for rehabilitation 252\u003c\/p\u003e \u003cp\u003eStandards of rehabilitation practice 254\u003c\/p\u003e \u003cp\u003eRehabilitation criteria 254\u003c\/p\u003e \u003cp\u003eThe rehabilitation process 255\u003c\/p\u003e \u003cp\u003eGoals of rehabilitation 256\u003c\/p\u003e \u003cp\u003eConcepts underpinning rehabilitation 256\u003c\/p\u003e \u003cp\u003ePlanning the rehabilitation programme content 256\u003c\/p\u003e \u003cp\u003eScheduling the programme 257\u003c\/p\u003e \u003cp\u003eCommunity-based rehabilitation (CBR) 257\u003c\/p\u003e \u003cp\u003eConclusion 260\u003c\/p\u003e \u003cp\u003e\u003cb\u003e28 Early Stimulation Programmes 263\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 263\u003c\/p\u003e \u003cp\u003eDefinition of early stimulation programme 263\u003c\/p\u003e \u003cp\u003eBackground 263\u003c\/p\u003e \u003cp\u003eObjectives of introducing an early stimulation programme (ESP) 263\u003c\/p\u003e \u003cp\u003eSetting up the ESP 264\u003c\/p\u003e \u003cp\u003eContent of the ESP 264\u003c\/p\u003e \u003cp\u003eSpecific techniques 265\u003c\/p\u003e \u003cp\u003eHow to encourage the involvement of family or friends 265\u003c\/p\u003e \u003cp\u003e\u003cb\u003e29 Discharge Planning 266\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 266\u003c\/p\u003e \u003cp\u003eWhat is discharge planning? 266\u003c\/p\u003e \u003cp\u003eBenefits of discharge planning 266\u003c\/p\u003e \u003cp\u003eDischarge planning process 266\u003c\/p\u003e \u003cp\u003eCriteria for discharge planning 267\u003c\/p\u003e \u003cp\u003eSelecting the discharge destination 267\u003c\/p\u003e \u003cp\u003eThe day of discharge 267\u003c\/p\u003e \u003cp\u003eConclusion 267\u003c\/p\u003e \u003cp\u003e\u003cb\u003e30 Living in the Community 270\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 270\u003c\/p\u003e \u003cp\u003eIntegrating into the community 270\u003c\/p\u003e \u003cp\u003e\u003cb\u003e31 Legal Matters 271\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eAndrew Warlow and Simon Parford\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 271\u003c\/p\u003e \u003cp\u003eCompensation claims arising out of head injuries 271\u003c\/p\u003e \u003cp\u003eBrain injury and medical negligence 273\u003c\/p\u003e \u003cp\u003eHead injuries 273\u003c\/p\u003e \u003cp\u003eThe cost of brain injury 276\u003c\/p\u003e \u003cp\u003e\u003cb\u003e32 Meeting Tomorrow’s Challenges 277\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNadine Abelson-Mitchell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eConclusion 277\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 6 Appendices 279\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAppendix 1 Pre-Admission Assessment 281\u003c\/p\u003e \u003cp\u003eInstructions 281\u003c\/p\u003e \u003cp\u003ePre-admission assessment 282\u003c\/p\u003e \u003cp\u003eFamily information 282\u003c\/p\u003e \u003cp\u003ePrevious health history 283\u003c\/p\u003e \u003cp\u003eCurrent health status 283\u003c\/p\u003e \u003cp\u003eHealth needs 286\u003c\/p\u003e \u003cp\u003eAppendix 2 Discharge Report 293\u003c\/p\u003e \u003cp\u003eInstructions 293\u003c\/p\u003e \u003cp\u003eSection A 293\u003c\/p\u003e \u003cp\u003eSection B 294\u003c\/p\u003e \u003cp\u003eSection C 294\u003c\/p\u003e \u003cp\u003eSection D 294\u003c\/p\u003e \u003cp\u003eActivity Answers 299\u003c\/p\u003e \u003cp\u003eAdditional Resources 309\u003c\/p\u003e \u003cp\u003eGlossary 315\u003c\/p\u003e \u003cp\u003eReferences 317\u003c\/p\u003e \u003cp\u003eIndex 333\u003c\/p\u003e \u003cp\u003eColour plate section can be found between pages 106 and 107\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49407917359447,"sku":"9781405185646","price":47.95,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781405185646.jpg?v=1730500952","url":"https:\/\/bookcurl.com\/products\/neurotrauma-9781405185646","provider":"Book Curl","version":"1.0","type":"link"}